Evidence map›Paper›PMID 35969437›Full record

ArticleJMIR formative research2022

Validation of the Mobile App Version of the EQ-5D-5L Quality of Life Questionnaire Against the Gold Standard Paper-Based Version: Randomized Crossover Study.

Regina J M Kamstra, André Boorsma, Tanja Krone, Robin M van Stokkum, Hannah M Eggink, Ton Peters, Wilrike J Pasman

Registry-linked trialAbstract read
In one paragraph

Article in JMIR formative research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07424378 (Randomized Controlled Trial of Epoprostenol Versus Placebo in Addition to Standard Therapy for Severe Frostbite Injury), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07424378 phase4not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Randomized Controlled Trial of Epoprostenol Versus Placebo in Addition to Standard Therapy for Severe Frostbite Injury

TypeinterventionalSponsorUniversity of Colorado, DenverRan2026 to 2028Enrolled66ConditionsFrostbiteArmsStandard of care plus Epoprostenol infusion for 8 hours (hrs) per day up to 5 days maximum, Standard of Care + Placebo (Normal Saline)infusion for 8 hours per day up to 5 days maximum
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Regina J M KamstraNetherlands Organization for Applied Scientific Research (TNO), Zeist, Netherlands.ORCID https://orcid.org/0000-0001-9837-2643
André BoorsmaNetherlands Organization for Applied Scientific Research (TNO), Zeist, Netherlands.ORCID https://orcid.org/0000-0001-6740-7022
Tanja KroneNetherlands Organization for Applied Scientific Research (TNO), Utrecht, Netherlands.ORCID https://orcid.org/0000-0003-4902-9907
Robin M van StokkumNetherlands Organization for Applied Scientific Research (TNO), Utrecht, Netherlands.ORCID https://orcid.org/0000-0002-1988-9896
Hannah M EgginkNetherlands Organization for Applied Scientific Research (TNO), Zeist, Netherlands.ORCID https://orcid.org/0000-0002-6951-7345
Ton PetersJanssen-Cilag B V, Breda, Netherlands.ORCID https://orcid.org/0000-0002-9697-5421
Wilrike J PasmanNetherlands Organization for Applied Scientific Research (TNO), Zeist, Netherlands.ORCID https://orcid.org/0000-0001-6962-2674

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStudy participants and patients often perceive (long) questionnaires as burdensome. In addition, paper-based questionnaires are prone to errors such as (unintentionally) skipping questions or filling in a wrong type of answer. Such errors can be prevented with the emergence of mobile questionnaire apps.

objectiveThis study aimed to validate an innovative way to measure the quality of life using a mobile app based on the EQ-5D-5L questionnaire. This validation study compared the EQ-5D-5L questionnaire requested by a mobile app with the gold standard paper-based version of the EQ-5D-5L.

methodsThis was a randomized, crossover, and open study. The main criteria for participation were participants should be aged ≥18 years, healthy at their own discretion, in possession of a smartphone with at least Android version 4.1 or higher or iOS version 9 or higher, digitally skilled in downloading the mobile app, and able to read and answer questionnaires in Dutch. Participants were recruited by a market research company that divided them into 2 groups balanced for age, gender, and education. Each participant received a digital version of the EQ-5D-5L questionnaire via a mobile app and the EQ-5D-5L paper-based questionnaire by postal mail. In the mobile app, participants received, for 5 consecutive days, 1 question in the morning and 1 question in the afternoon; as such, all questions were asked twice (at time point 1 [App T1] and time point 2 [App T2]). The primary outcomes were the correlations between the answers (scores) of each EQ-5D-5L question answered via the mobile app compared with the paper-based questionnaire to assess convergent validity.

resultsA total of 255 participants (healthy at their own discretion), 117 (45.9%) men and 138 (54.1%) women in the age range of 18 to 64 years, completed the study. To ensure randomization, the measured demographics were checked and compared between groups. To compare the results of the electronic and paper-based questionnaires, polychoric correlation analysis was performed. All questions showed a high correlation (0.64-0.92; P<.001) between the paper-based and the mobile app-based questions at App T1 and App T2. The scores and their variance remained similar over the questionnaires, indicating no clear difference in the answer tendency. In addition, the correlation between the 2 app-based questionnaires was high (>0.73; P<.001), illustrating a high test-retest reliability, indicating it to be a reliable replacement for the paper-based questionnaire.

conclusionsThis study indicates that the mobile app is a valid tool for measuring the quality of life and is as reliable as the paper-based version of the EQ-5D-5L, while reducing the response burden.

Indexed as

EQ-5D-5L questionnairemobile appmobile phonequality of life assessmenttest-retest reliability

Identifiers

PMID35969437
PMCPMC9412727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.